Differences in disease complication prevalences between centers
Complication . | Prevalence by center, % . | P . | ||||
---|---|---|---|---|---|---|
Gothenberg . | Stockholm . | Freiburg . | Oxford . | Brno . | ||
Iron deficiency | 22 | 4 | 18 | 56 | 29 | < .001 |
Lymphadenopathy: persistent | 0 | 7 | 9 | 23 | 42 | < .001 |
Splenomegaly | 3 | 19 | 46 | 30 | 66 | < .001 |
Bronchiectasis | 14 | 4 | 16 | 52 | 27 | < .001 |
No complications | 43 | 46 | 24 | 12 | 5 | < .001 |
Lymphoid interstitial pneumonitis | 0 | 0 | 0 | 10 | 0 | < .001 |
Hepatomegaly: unexplained | 0 | 5 | 13 | 15 | 7 | .008 |
Granuloma: unexplained | 4 | 2 | 10 | 16 | 5 | .01 |
Immune thrombocytopenia | 3 | 4 | 12 | 13 | 0 | .01 |
Psoriasis | 0 | 2 | 0 | 6 | 0 | .02 |
Enteropathy: unexplained | 3 | 4 | 10 | 13 | 15 | .06 |
Pernicious anemia | 4 | 18 | 10 | 6 | 10 | .08 |
Autoimmune hemolytic anemia | 1 | 4 | 3 | 8 | 0 | .08 |
Thyrotoxicosis | 0 | 0 | 0 | 2 | 0 | .26 |
Hypothyroidism | 0 | 4 | 6 | 5 | 7 | .28 |
Persistent arthropathy | 1 | 2 | 6 | 2 | 5 | .46 |
Neutropenia | 0 | 2 | 0 | 1 | 2 | .66 |
Vitiligo | 6 | 5 | 6 | 5 | 5 | 1.0 |
Complication . | Prevalence by center, % . | P . | ||||
---|---|---|---|---|---|---|
Gothenberg . | Stockholm . | Freiburg . | Oxford . | Brno . | ||
Iron deficiency | 22 | 4 | 18 | 56 | 29 | < .001 |
Lymphadenopathy: persistent | 0 | 7 | 9 | 23 | 42 | < .001 |
Splenomegaly | 3 | 19 | 46 | 30 | 66 | < .001 |
Bronchiectasis | 14 | 4 | 16 | 52 | 27 | < .001 |
No complications | 43 | 46 | 24 | 12 | 5 | < .001 |
Lymphoid interstitial pneumonitis | 0 | 0 | 0 | 10 | 0 | < .001 |
Hepatomegaly: unexplained | 0 | 5 | 13 | 15 | 7 | .008 |
Granuloma: unexplained | 4 | 2 | 10 | 16 | 5 | .01 |
Immune thrombocytopenia | 3 | 4 | 12 | 13 | 0 | .01 |
Psoriasis | 0 | 2 | 0 | 6 | 0 | .02 |
Enteropathy: unexplained | 3 | 4 | 10 | 13 | 15 | .06 |
Pernicious anemia | 4 | 18 | 10 | 6 | 10 | .08 |
Autoimmune hemolytic anemia | 1 | 4 | 3 | 8 | 0 | .08 |
Thyrotoxicosis | 0 | 0 | 0 | 2 | 0 | .26 |
Hypothyroidism | 0 | 4 | 6 | 5 | 7 | .28 |
Persistent arthropathy | 1 | 2 | 6 | 2 | 5 | .46 |
Neutropenia | 0 | 2 | 0 | 1 | 2 | .66 |
Vitiligo | 6 | 5 | 6 | 5 | 5 | 1.0 |
The P value provides the statistical evidence against the hypothesis of equal intercenter rates for each disease complication.